Results 201 to 210 of about 2,740,870 (362)

Metabolic Consequences of Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry, Emily Sheng, Joshua F. Baker   +2 more
wiley   +1 more source

Determinants of -Glutamyltransferase: Positive Interaction with Alcohol and Body Mass Index, Negative Association with Coffee [PDF]

, 1997
Kari Poikolainen, Erkki Vartiainen
openalex   +1 more source

Body Mass Index as an Example of a Negative Confounder: Evidence and Solutions. [PDF]

Genes (Basel)
Jiesisibieke ZL, Schooling CM.
europepmc   +1 more source

Association of Higher Levels of High‐Sensitivity C‐Reactive Protein With Future Development of Psoriatic Arthritis in Psoriasis: A Prospective Cohort Study

Arthritis Care &Research, EarlyView.
Objective We aimed to assess whether high‐sensitivity C‐reactive protein (hsCRP) levels could predict the development of psoriatic arthritis (PsA) in patients with psoriasis. Methods We analyzed data from a prospective cohort of patients with psoriasis without PsA at enrollment.
Lihi Eder, Xianwei Li, Vinod Chandran, Cheryl F. Rosen, Richard J. Cook, Dafna D. Gladman   +5 more
wiley   +1 more source

228 BODY MASS INDEX AS AN INDICATOR OF OVERFATHESS IN YOUNG BLACK CHILDREN

, 1994
David A. Rowe
openalex   +1 more source

Body mass index and post-menopausal breast cancer: an age-specific analysis [PDF]

, 1997
Carlo La Vecchia, Eva Negri, Silvia Franceschi, Renato Talamini, Paolo Bruzzi, Domenico Palli, Adriano Decarli   +6 more
openalex   +1 more source

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score–Matched Cohort Study

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to evaluate and compare the risk of hepatotoxicity associated with the use of febuxostat and benzbromarone in patients with gout. Methods New users of febuxostat or benzbromarone with monitoring of liver function at least three times in a year after initiation of the study drugs were identified from an ...
Wenyan Sun, Lingling Cui, Robert Terkeltaub, Ying Chen, Xinde Li, Xiaoyu Cheng, Tian Liu, Nicola Dalbeth, Changgui Li   +8 more
wiley   +1 more source

Reassessment of Body Mass Index for Screening Obesity.

, 1992
Shuichi Komiya, Yasuhiro MURAOKA, Katsumi Imai, Takashi Masuda   +3 more
openalex   +2 more sources

The Gut Microbiome as a Key Determinant of the Heritability of Body Mass Index. [PDF]

Nutrients
Barber TM, Kabisch S, Pfeiffer AFH, Weickert MO.   +3 more
europepmc   +1 more source

Colchicine Concentrations and Relationship With Colchicine Efficacy and Adverse Events: Post Hoc Analysis of a Randomized Clinical Trial of Colchicine for Gout Flare Prophylaxis

Arthritis Care &Research, EarlyView.
Objective Our objective was to examine the relationship between colchicine plasma concentrations and clinical and demographic factors and to determine the relationship between colchicine concentrations and colchicine efficacy and colchicine‐specific adverse events.
Lisa K. Stamp, Anne Horne, Borislav Mihov, Jill Drake, Janine Haslett, Peter Chapman, Daniel F. B. Wright, Christopher Frampton, Nicola Dalbeth   +8 more
wiley   +1 more source